Related Experiment Video
Updated: Apr 17, 2026

Purifying the Impure: Sequencing Metagenomes and Metatranscriptomes from Complex Animal-associated Samples
Published on: December 22, 2014
16S community profiling identifies proton pump inhibitor related differences in gastric, lung, and oropharyngeal
Rachel Rosen1, Lan Hu2, Janine Amirault1
1Aerodigestive Center, Division of Gastroenterology and Nutrition, Boston Children's Hospital, Boston, MA.
Insights
Proton pump inhibitor (PPI) use alters gut bacteria, potentially affecting lung and throat microbes through reflux. Gastric and lung bacteria showed closer relationships, suggesting aspiration of reflux contributes to these changes.
Area of Science:
- Microbiology
- Gastroenterology
- Pulmonology
Background:
- Proton pump inhibitors (PPIs) are widely used medications.
- Their impact on the human microbiome, particularly in the upper gastrointestinal and respiratory tracts, is an area of ongoing research.
- Understanding these effects is crucial for evaluating potential side effects and optimizing treatment.
Purpose of the Study:
- To investigate the hypothesis that proton pump inhibitor (PPI) use leads to alterations in gastric microflora.
- To determine if these gastric microflora changes, via full column reflux, subsequently affect lung and oropharyngeal microflora.
- To explore the relationship between PPI dosage and observed microflora changes.
Main Methods:
- A prospective, cross-sectional cohort study involving 116 children with chronic cough.
- Participants were divided into two groups: those on PPIs (n=59) and those not on PPIs (n=57).
- Simultaneous bronchoscopy and upper endoscopy were performed, with 16S sequencing of gastric, bronchoalveolar lavage, and oropharyngeal fluids. Multichannel intraluminal impedance testing was conducted on 50 patients.
Main Results:
- Increased abundance of Streptococcus in the gastric fluid of children on PPIs, correlating with PPI dosage.
- Significant differences in oropharyngeal Streptococcus abundance were observed in PPI-treated patients.
- Eight bacterial genera were found in gastric and lung fluids but not oropharyngeal, indicating site exchange. Lactococcus and Acinetobacter were more abundant with greater reflux, suggesting aspiration. Principal component analysis showed greater overlap between gastric and lung microflora compared to oropharyngeal.
Conclusions:
- Proton pump inhibitor (PPI) use is associated with distinct changes in gastric, lung, and oropharyngeal microflora.
- While microflora exchange occurs among these sites, gastric and lung microflora exhibit a closer relationship.
- Aspiration of full column reflux is proposed as a potential mechanism for microflora exchange between the gastric and lung environments.
Objectives:
To test the hypothesis that proton pump inhibitor (PPI) use results in changes in gastric microflora which, through full column reflux, results in lung and oropharyngeal microflora changes.
Study Design:
We performed a prospective, cross-sectional cohort study of 116 children (57 off and 59 on PPIs) undergoing simultaneous bronchoscopy and upper endoscopy for the evaluation of chronic cough. We performed 16S sequencing on gastric, bronchoalveolar lavage, and oropharyngeal fluid. Fifty patients also underwent multichannel intraluminal impedance testing.
Results:
Streptococcus was more abundant in the gastric fluid of patients taking PPIs, and there was a significant correlation with PPI dose (mg/kg/d) and abundance of gastric Streptococcus (P = .01). There was also a significant difference in the abundance of oropharyngeal Streptococcus in patients treated with PPI. Eight unique bacterial genera were found in the gastric and lung fluid but not in the oropharyngeal suggesting exchange between the 2 sites and 2 of the 8 (Lactococcus, Acinetobacter) were more abundant in patients with more full column reflux, suggesting direct aspiration. Principal component analysis revealed greater overlap between gastric and lung than oropharyngeal microflora.
Conclusions:
PPI use was associated with differences in gastric, lung, and oropharyngeal microflora. Although microflora exchange can occur between all 3 sites, gastric and lung microflora are more closely related, and the mechanism of exchange between sites may be aspiration of full column reflux.
Related Concept Videos
Microbiota of the Stomach and Small Intestine
Microbiota of the Respiratory Tract
Probiotics
The Oral Microbiota
What is Monogastric Digestion?
Microbiota of the Large Intestine

